EUVIMEDEUVIMED entdecken
Crossref

Molecular characterisation and susceptibility to in vitro antifungal drugs ofclinical and environmental Penicillium isolates in Mazandaran, Iran

Leila Faeli, Abbas Raeisabadi, Mohsen Nosratabadi, Robab Ebrahimi Barough, Maryam Moazeni, Reza Valadan, Neda Kiasat, Ali Rezaei-Matehkolaei, Iman Haghani, Ahmed Al-Harrasi, Mahdi Abastabar, Abdullah M.S. Al-Hatmi

One Health Mycology · 2023

DOI: 10.63049/ohm.25.22.4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift One Health Mycology, 2023. Verfasst von Leila Faeli und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Humans occasionally show opportunistic infections by Penicillium species, which can range from superficial to widespread and potentially lethal. Different species of Penicillium exhibit varying levels of resistance to various antifungal medications. Very limited information is available on the antifungal susceptibility profiles of environmental and clinical Penicillium species worldwide.

Methods

The isolates underwent phenotypical evaluation based on standard growth criteria, followed by molecular identification through sequencing of the β-tubulin gene. We tested 12 antifungal drugs in vitro against 53 Penicillium isolates collected from both clinical and environmental origins according to CLSI document M38-A3.

Results

In clinical settings, Penicillium species exhibited high MIC values against the most commonly used antifungal medications. At 0.021 and 0.093 µg/mL, respectively, lanoconazole and luliconazole showed extremely low geometric mean MIC values, followed by 0.366 µg/mL for amphotericin B, 0.473 µg/mL for itraconazole and 0.640 µg/mL for ketoconazole.

Conclusions

Luliconazole has potential as a treatment for superficial infections caused by Penicillium. More in vivo and in vitro research as well as the development of systemic formulations may aid in the treatment of systemic penicilliosis.

Zitieren

APA

Faeli, L., Raeisabadi, A., Nosratabadi, M., Barough, R. E., Moazeni, M., Valadan, R., Kiasat, N., Rezaei-Matehkolaei, A., Haghani, I., Al-Harrasi, A., Abastabar, M., & Al-Hatmi, A. M. (2023). Molecular characterisation and susceptibility to in vitro antifungal drugs ofclinical and environmental Penicillium isolates in Mazandaran, Iran. One Health Mycology. https://doi.org/10.63049/ohm.25.22.4

Vancouver

Faeli L, Raeisabadi A, Nosratabadi M, Barough RE, Moazeni M, Valadan R, et al. Molecular characterisation and susceptibility to in vitro antifungal drugs ofclinical and environmental Penicillium isolates in Mazandaran, Iran. One Health Mycology. 2023. doi:10.63049/ohm.25.22.4

BibTeX
@article{Faeli2023,
  author = {Faeli, Leila and Raeisabadi, Abbas and Nosratabadi, Mohsen and Barough, Robab Ebrahimi and Moazeni, Maryam and Valadan, Reza and Kiasat, Neda and Rezaei-Matehkolaei, Ali and Haghani, Iman and Al-Harrasi, Ahmed and Abastabar, Mahdi and Al-Hatmi, Abdullah M.S.},
  title = {Molecular characterisation and susceptibility to in vitro antifungal drugs ofclinical and environmental Penicillium isolates in Mazandaran, Iran},
  journal = {One Health Mycology},
  year = {2023},
  doi = {10.63049/ohm.25.22.4}
}
Kostenlos starten →